Studio Retrospettivo-Prospettico Sulle Cause Del Mancato Raggiungimento Del Target Di Emoglobina Glicata Nei Pazienti Con Diabete Mellito Tipo 2 Nel Setting Della Medicina Generale
Barra laterale dell'articolo
Contenuto principale dell'articolo
Abstract
Il diabete di tipo 2 rappresenta attualmente una delle principali sfide cliniche e organizzative per la medicina generale. Nonostante la disponibilità di linee guida aggiornate e di terapie farmacologiche sempre più efficaci, nella pratica quotidiana si osserva come una percentuale significativa di pazienti non riesca a raggiungere o mantenere un adeguato controllo glicemico nel tempo.
La maggior parte di questi pazienti viene gestita in medicina generale, che rappresenta il primo e più stabile punto di contatto con il sistema sanitario.
Lo studio, retrospettivo-prospettico, osservazionale e condotto presso un singolo ambulatorio di medicina generale, ha incluso pazienti adulti con diagnosi di diabete mellito di tipo 2, in trattamento farmacologico o dietetico, con almeno due controlli dell'HbA1c nell'ultimo anno.
Tale contesto riflette fedelmente la realtà quotidiana della medicina generale italiana. L'analisi dei dati ha identificato una serie di fattori ricorrenti associati al mancato raggiungimento dell'obiettivo glicemico.
Downloads
Dettagli dell'articolo
Questo lavoro è fornito con la licenza Creative Commons Attribuzione - Non commerciale 4.0 Internazionale.
Riferimenti bibliografici
• American Diabetes Association. Standards of Medical Care in Diabetes—2024. Diabetes Care. 2024;47(Suppl.1):S1–S203.
• Davies MJ, D’Alessio DA, Fradkin J, et al. Management of Hyperglycemia in Type 2 Diabetes, 2023: A Consensus Report by the ADA and the EASD. Diabetologia. 2023;66(3):499–511.
• Società Italiana di Diabetologia (SID), Associazione Medici Diabetologi (AMD). Standard italiani per la cura del diabete mellito 2022. Roma: SID-AMD; 2022.
• Khunti K, Davies MJ. Clinical inertia—time to reappraise the terminology? Prim Care Diabetes. 2017;11(2):105–106.
• Reach G. Patient non-adherence and healthcare-provider inertia are clinical myopia. Diabetes Metab. 2008;34(4):382–385.
• Gonzalez JS, Safren SA, Cagliero E, et al. Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care. 2007;30(9):2222–2227.
• Holt RIG, de Groot M, Golden SH. Diabetes and depression. Curr Diab Rep. 2014;14(6):491.
• World Health Organization. Global report on diabetes. Geneva: WHO; 2016.
• International Diabetes Federation. IDF Diabetes Atlas, 10th edition. Brussels: IDF; 2023.
• Peyrot M, Rubin RR, Lauritzen T, et al. Psychosocial problems and barriers to improved diabetes management: results of the DAWN2 study. Diabet Med. 2013;30(7):772–783.
• Fisher L, Polonsky WH, Hessler DM, et al. Understanding the sources of diabetes distress in adults with type 2 diabetes. J Diabetes Complications. 2015;29(4):572–577.
• Riddle MC, Cefalu WT, Evans PH, et al. Addressing clinical inertia in type 2 diabetes: a consensus statement. Diabetes Ther. 2018;9(4):1733– 1754.
• Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299–1307.
• Ceriello A, DeVries JH. New drugs for the treatment of diabetes: impact on glycemic control and cardiovascular risk. Diabetologia. 2019;62(6):870– 880.
• Karter AJ, Subramanian U, Saha C, et al. Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care. 2010;33(4):733–735.
• Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach. Diabetes Care. 2015;38(1):140–149.
• Reach G, Michault A, Bihan H, Paulino C, Cohen R, Leclercq C. Patients’ perceptions of insulin therapy and of physicians’ attitudes toward insulin prescribing: the UTOPIA study. Diabetes Metab. 2007;33(3):220–226.
• NICE. Type 2 diabetes in adults: management (NG28). National Institute for Health and Care Excellence; 2022.
• Aujoulat I, d’Hoore W, Deccache A. Patient empowerment in theory and practice: polysemy or cacophony? Patient Educ Couns. 2007;66(1):13– 20.
• Bandura A. Self-efficacy: The exercise of control. New York: W.H. Freeman; 1997.
• Glasgow RE, Toobert DJ, Gillette CD. Psychosocial barriers to diabetes self-management and quality of life. Diabetes Spectrum. 2001;14(1):33–41.
• Snoek FJ, Skinner TC. Psychological aspects of diabetes management. Medicine. 2002;30(2):76–78.
• O’Connor PJ, Sperl-Hillen JM, Johnson PE, Rush WA, Biltz G. Clinical inertia and outpatient medical errors. Adv Patient Saf. 2005;1:293–308.
• Greenfield S, Kaplan SH, Ware JE Jr, et al. Patients’ participation in medical care: effects on blood sugar control and quality of life in diabetes. J Gen Intern Med. 1988;3(5):448–457.
• Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. 3rd ed. New York: Guilford Press; 2012.
• Cutrona SL, Choudhry NK, Stedman M, et al. Physician effectiveness in interventions to improve medication adherence: a meta-analysis. J Gen Intern Med. 2010;25(12):1365–1376.
• Bojadzievski T, Gabbay RA. Patient-centered medical home and diabetes. Diabetes Care. 2011;34(4):1047–1053.
• Rossi MC, Lucisano G, Comaschi M, et al. Quality of diabetes care predicts the development of cardiovascular events: results of the AMD-QUASAR study. Diabetes Care. 2011;34(2):347–352.
• Vainio H, Kaunisto M, Jokinen M, et al. A primary care approach to improving diabetes outcomes: experiences from Finland. Scand J Prim Health Care. 2020;38(4):381–389.
• De Berardis G, Pellegrini F, Franciosi M, et al. Long-term quality of diabetes care predicts complications: a prospective study in primary care. Diabetes Care. 2004;27(3):697–703.
• Lorig KR, Holman HR. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003;26(1):1–7.
• Renders CM, Valk GD, Griffin SJ, et al. Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care. 2001;24(10):1821–1833.
• Politi MC, Wolin KY, Legare F. Implementing shared decision making in routine practice: barriers and opportunities. Patient Educ Couns. 2013;90(3):307–312.
• Holt RIG, Barnard KD, Reaney MD, et al. The role of psychology in diabetes care: time for a paradigm shift. Diabet Med. 2010;27(7):760–765.
• Pellegrini F, De Berardis G, Franciosi M, et al. Quality of care and outcomes in type 2 diabetes patients in Italy: findings from the QuED study. Diabetes Care. 2005;28(11):2833–2838.
• Boehm S, Petzold M, Holmberg C, et al. Diabetes self-management education in primary care: results from a systematic review and meta-analysis. Patient Educ Couns. 2021;104(6):1421–1432.
• Rossi MC, Nicolucci A. Il ruolo della medicina generale nella gestione del diabete di tipo 2 in Italia: sfide e prospettive future. Recenti Prog Med. 2022;113(11):650–659.
• Ministero della Salute. Piano Nazionale per la Cronicità (PNC). Roma: Ministero della Salute; 2016.
• Istituto Superiore di Sanità. Linee di indirizzo per la presa in carico delle persone con diabete mellito. Roma: ISS; 2022.
• World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003.